Sensei Biotherapeutics (SNSE) Stock Statistics & Valuation Metrics

Sensei Biotherapeutics has a market cap or net worth of $12.02M. The enterprise value is -$15.25M.

Sensei Biotherapeutics has 1,261,290 shares outstanding. The number of shares has decreased by -2.65% in one year.

Sensei Biotherapeutics’s return on equity (ROE) is -0.79 and return on invested capital (ROIC) is -77.23%.

The current PE Ratio of Sensei Biotherapeutics is ―. Sensei Biotherapeutics’s PEG ratio is 4.98.

In the last 12 months, Sensei Biotherapeutics had revenue of 0.00 and earned -30.16M in profits. Earnings per share was -1.20.

In the last 12 months, operating cash flow was -22.38M and capital expenditures -16.00K, giving a free cash flow of -22.40M billion.

Sensei Biotherapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Sensei Biotherapeutics upcoming earnings date is Mar 26, 2026, Before Open (Confirmed).

Sensei Biotherapeutics as a current ratio of 7.70, with Debt / Equity ratio of 8.78%

In the past 12 months, Sensei Biotherapeutics has paid 0.00 in taxes.

Sensei Biotherapeutics EV to EBITDA ratio is -8.13, with an EV/FCF ratio of -9.67.

Sensei Biotherapeutics has $25.04M in cash and marketable securities with $2.02M in debt, giving a net cash position of $23.02M billion.

Gross margin is 37.68%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Sensei Biotherapeutics is ―, which is 11.43% higher than the current price. The consensus rating is Hold